Interview with Rod S Passman, MD. Director, Center for Arrhythmia Research
2023/04/25
再生時間： 26 分
ポッドキャスト

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

Interview with Rod S Passman, MD. Director, Center for Arrhythmia Research

無料で聴く

ポッドキャストの詳細を見る

サマリー
Rod S Passman, MD is interviewed by Happitech CEO and Founder Yosef Safi Harb

Rod S Passman, MD is Director, Center for Arrhythmia Research and Jules J. Reingold Professor of Electrophysiology, Professor of Medicine (Cardiology) and Preventative Medicine
An innovator for patients in Atrial Fibrillation, Dr. Passman is a highly regarded cardiac electrophysiologist and is an internationally recognized leader in cardiac monitoring and stroke prevention.
Dr. Passman pioneered the use of implantable cardiac monitors to search for atrial fibrillation in stroke patients, a strategy now part of standard practice around the world. His current research focuses on implantable and wearable heart monitors to guide the use of anticoagulants in patients with atrial fibrillation.
In this wide-ranging interview Dr Passman describes some of the benefits for patients of the emergence of consumer-style devices for remote patient monitoring. Dr. Passman also calls for more small-scale research studies, in partnership with the manufacturers of these devices, to evidence their ability to improve patient outcomes and save healthcare costs to encourage reimbursement by Payers.

続きを読む一部表示

あらすじ・解説

Rod S Passman, MD is interviewed by Happitech CEO and Founder Yosef Safi Harb

Rod S Passman, MD is Director, Center for Arrhythmia Research and Jules J. Reingold Professor of Electrophysiology, Professor of Medicine (Cardiology) and Preventative Medicine

An innovator for patients in Atrial Fibrillation, Dr. Passman is a highly regarded cardiac electrophysiologist and is an internationally recognized leader in cardiac monitoring and stroke prevention.

Dr. Passman pioneered the use of implantable cardiac monitors to search for atrial fibrillation in stroke patients, a strategy now part of standard practice around the world. His current research focuses on implantable and wearable heart monitors to guide the use of anticoagulants in patients with atrial fibrillation.

In this wide-ranging interview Dr Passman describes some of the benefits for patients of the emergence of consumer-style devices for remote patient monitoring. Dr. Passman also calls for more small-scale research studies, in partnership with the manufacturers of these devices, to evidence their ability to improve patient outcomes and save healthcare costs to encourage reimbursement by Payers.

続きを読む一部表示